TT11X is an “off-the-shelf”, genetically modified cell therapy being trialed for...
The company plans to finish the round by September or October at the latest.
This comes amongst various wins for Keytruda in recent years.
The first patient has been dosed with Osivax’s broad-spectrum candidate in its P...
Pleural mesothelioma represents 85% of new mesothelioma cases, followed by perit...
The grant comes after Flamingo announced a deal in March 2023 to merge its opera...
Testosterone supplementation in men with low levels of the hormone did not incre...
A U.K. trade group has rebuked Leo Pharma over an incident in which a company ma...
The FDA discovered another troubled plant run by Intas Pharmaceuticals, a generi...
Getting rid of bias in clinical calculators isn't as simple as taking race out o...
“I think the trend is moving away from BMI, but these entrenched issues don’t fa...
Genomic data from the tumors of more than 4,000 dogs is offering insights for tr...
The problem with the new Alzheimer’s drugs isn’t the drugs.
On Thursday, the FDA's scientific advisers said the next round of Covid vaccines...
In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...
Can unicorns survive without data? Did biotech get over its skis? And what is go...
